Seasonal Allergy Shots: How Many, How Often, and Why So Many Visits
Seasonal allergy shots are a multi-injection course — typically 60–80 total injections across 3–5 years — targeting the specific pollens that drive a patient's hay-fever symptoms. Cox 2011 PP3 specifies Year 1 as approximately 39 in-clinic visits (weekly build-up plus early maintenance), then 14 visits per year during maintenance. Understanding the visit count before starting is critical: 23.9% of patients never return after injection one.
7 peer-reviewed sources
Seasonal allergy shots are not a single yearly injection — they are a 60-to-80-injection multi-year course. Year 1 requires approximately 39 in-clinic visits; Years 2–5 average 14 visits per year.
The essentials
Seasonal allergy shots are a multi-injection SCIT regimen — the "shots" in the plural name matters clinically. A typical 4-year course for a seasonal-allergic patient adds up to approximately 39 Year-1 visits plus 3 × 14 maintenance years = approximately 81 in-office visits total, each followed by a mandatory 30-minute post-injection observation period under Cox 2011 PP3. Patients who expect a once-or-twice-yearly appointment are consistently surprised by this reality, which is why adherence data is as important as efficacy data.
Curex starts every patient with at-home IgE testing and allergist review to determine which seasonal pollens are clinically relevant — narrowing the extract menu before committing to a multi-year immunotherapy schedule.
The two-phase count breaks down as follows per Cox 2011 PP3. During conventional build-up — 26–28 weekly injections over approximately 4–6 months — the extract concentration escalates from a highly diluted starting dose (approximately 1:10,000 of maintenance concentration) up to near-maintenance levels. Dose increments per visit are typically 10–20% with a standard 4-vial color-coded ladder (common US practice, though vial colors are not an industry-standardized requirement per Prudenti 2023 — patients should read labels, not color). Why so many increments? SCIT is dose-driven: effective maintenance dose targets for seasonal pollens include approximately 7 µg Phl p 5 (timothy grass) and 7–20 µg Amb a 1 (short ragweed major allergen) per Cox 2011 PP3. Reaching those doses safely from starting dilutions of 1:10,000 to 1:1,000,000 of maintenance concentration requires the gradual ladder.
Early maintenance (13 visits at the therapeutic dose, included in the Year-1 count) transitions into full maintenance at every 2–4 weeks for Years 2–5. The 30-minute post-injection observation remains mandatory at every maintenance visit — not just during build-up. Some practices extend maintenance intervals to 6 weeks in stable patients; longer intervals are not supported by the Cox 2011 practice parameter without individual risk stratification.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The seasonal allergy shots timeline follows three phases. Visit count drives adherence — planning the full schedule before starting significantly improves completion.
26–28 weekly visits with escalating extract doses. Cluster regimens (Tabar AI et al., JACI 2005; Cox 2011 PP3 Summary Statement 26) reach maintenance in 7–13 visits with appropriate premedication. Rush build-up (1–3 days, Bernstein 2008) carries a 5–15% systemic-reaction rate and requires intensive medical supervision. Every injection is followed by a mandatory 30-minute observation period.
Once at therapeutic maintenance dose, frequency drops to 14 visits per year on average. Gaps of more than 3–4 months typically require restarting from a lower dose. Only 43.9% of patients who initiate AIT reach maintenance per Tkacz 2021 (n=103,207, MarketScan). The 30-minute observation period remains mandatory at every maintenance visit.
Durham 1999 NEJM: 3 years of sustained clinical benefit after stopping a 3–4 year grass SCIT course, with persistent allergen-specific IgG4. PAT study (Jacobsen 2007): asthma-prevention benefit at 10-year follow-up in children. Full course completion is the key driver of durable remission.
Efficacy by allergen — what the data shows
The multi-injection commitment delivers proportional returns: completing more of the course yields progressively stronger and more durable benefits.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
How many allergy shots do you need in total for seasonal allergies?
A typical 4-year seasonal SCIT course totals approximately 81 in-clinic injections: approximately 39 in Year 1 (26–28 weekly build-up visits plus 13 early maintenance visits) and 14 visits per year in Years 2–4. A 5-year course adds another 14 = approximately 95 total injections. Cluster schedules (Tabar 2005) can reduce Year-1 visits substantially by delivering multiple injections per visit, reaching maintenance in 7–13 visits rather than 26–28 weekly appointments. The 30-minute post-injection observation at each visit adds approximately 30 hours of clinic time over a 4-year course beyond the injection itself.
Why do seasonal allergy shots require so many visits?
SCIT is dose-driven: the immune system must be exposed to gradually increasing allergen concentrations over many months to safely reach an effective maintenance dose without triggering systemic reactions. Cox 2011 PP3 specifies maintenance-dose targets of approximately 7 µg Phl p 5 for timothy grass and 7–20 µg Amb a 1 for short ragweed. Starting doses are diluted to approximately 1:10,000 to 1:1,000,000 of the maintenance concentration for safety. Jumping to maintenance concentration without the build-up ladder would produce unacceptable systemic-reaction rates. The 26–28 build-up visits exist to reach therapeutic dose safely, not as a revenue strategy.
Can I get seasonal allergy shots less frequently than weekly?
During build-up, the conventional schedule is weekly because each injection must build on the immunological changes of the previous one. Longer gaps between build-up injections require dose reductions to maintain safety. Once at maintenance, the schedule can extend to every 2–4 weeks and, in stable patients, some allergists may space to every 6 weeks based on individual tolerance. A cluster schedule can compress the build-up phase to 7–13 visits. Rush regimens can reach maintenance in 1–3 days but are associated with a 5–15% systemic-reaction rate and are typically reserved for venom immunotherapy or specific clinical situations.
What happens if I miss several seasonal allergy shot appointments?
Missing appointments during build-up requires going back to a lower dose. Gaps of more than approximately 2 weeks during conventional build-up may require dose reduction to the level of 2 weeks prior. During maintenance, a gap of more than 3–4 months typically requires restarting build-up from the beginning. This is one reason why adherence is so important and why 23.9% of patients who never return for injection one (Tkacz 2021) permanently forfeit any SCIT benefit. If travel or scheduling prevents you from keeping appointments, discuss interval extension options with your allergist before stopping.
Do seasonal allergy shots need to be started before pollen season?
In US practice, SCIT initiation is not restricted to off-season timing, but many allergists prefer starting build-up in fall or winter for grass- or ragweed-allergic patients to avoid initiating during peak pollen season. Cox 2011 PP3 notes that elevated baseline immune activation during peak pollen season increases systemic-reaction risk. Starting in low-pollen months allows safer dose escalation. Pre-seasonal SCIT (starting a build-up phase annually each year before pollen season, without year-round maintenance) is practiced more in European protocols and is uncommon in the US.
Is there a faster alternative to the seasonal allergy shot schedule?
Yes — cluster and rush build-up protocols can reach maintenance faster. A cluster regimen (Tabar 2005 JACI; Cox 2011 PP3 Summary Statement 26) delivers multiple injections per visit with appropriate premedication, reaching maintenance in approximately 7–13 visits rather than 26–28 weekly appointments. A rush protocol compresses build-up to 1–3 days but carries a 5–15% systemic-reaction rate and requires intensive medical supervision. FDA-approved SLIT tablets (Grastek for timothy grass, Oralair for 5-grass, Ragwitek for short ragweed) are not injections — they are daily oral and require only one supervised first-dose clinic visit, though they cover only specific pollens.
Do you need allergy shots every year for seasonal allergies?
SCIT is not a yearly treatment — it is a continuous 3–5 year course. After completing the course, disease-modifying benefits typically persist for 3–12 years without additional injections (Durham 1999 NEJM; Jacobsen 2007 PAT). Some patients require a second course after 10–15 years when remission wanes. The concept of a "yearly allergy shot" most commonly refers to a depot corticosteroid injection (Kenalog-40 or Depo-Medrol) — a symptomatic product the AAAAI/ACAAI rhinitis Practice Parameter discourages for routine seasonal AR management due to HPA-axis suppression risk.
Related Articles
Allergy Shot for Seasonal Allergies — Single Shot? | Curex
One allergy shot won't treat seasonal allergies — SCIT requires 60–80 injections over 3–5 years. A single IM steroid shot exists but is discouraged. Learn the real options.
Read moreSeasonal Allergy Shot Guide | Curex SCIT Resource
A seasonal allergy shot is SCIT targeting tree, grass, and weed pollens — not a yearly steroid. Cochrane 51 RCTs: symptom SMD −0.73. Learn the full regimen.
Read moreAllergy Shot: SCIT Guide for Patients | Curex
An allergy shot is subcutaneous immunotherapy (SCIT) — a 3-to-5-year course. Cochrane 51 RCTs found SMD -0.73. Learn how it works, costs, and who qualifies.
Read moreAllergy Desensitization: Which Treatment Type? | Curex
Allergy desensitization is active allergen-specific immunotherapy (SCIT or SLIT). Differs from passive immunotherapy and pharmacotherapy in mechanism.
Read moreAllergy Shots vs Drops: Evidence-Based Comparison | Curex
Allergy shots (SCIT) vs sublingual drops (SLIT): comparable efficacy per Nelson 2015, but SLIT has zero fatalities vs 1 per 2.5M shots. Full comparison.
Read moreAllergy Shots for Dust: What They Actually Target | Curex
'Dust allergy' almost always means house dust mite (Der p/Der f). SCIT and Odactra SLIT target specific components. At-home shots from Curex: $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.